Clinical Trial Update: dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation [Phase 2]

View source ↗

Summary

This Phase 2 randomized trial evaluates dApagliflozin SC0062 for the prevention of renal injury in Type 1 diabetes mellitus with diabetic nephropathy and is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus with Diabetic Nephropathy

Drugs mentioned

• dApagliflozin SC0062 (dApagliflozin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Type 1 Diabetes Mellitus With Diabetic Nephropathy | Phase 2 | Status: NOT_YET_RECRUITING